unter besonderer Berücksichtigung der Myeloperoxidase-Aktivität in Synovia von erkrankten Gelenken und Sehnenscheiden

Deckblatt-Impressum Table of Contents Abbreviation Index of Figures Indes of Tables Introduction Review of Literature Objectives Materials and Method Results Discussion Conclusion Summary Zusammenfassung References Acknowledgment SelbständigkeitserklärungObjective: The aim of the present work is to study the activity of the enzyme myeloperoxidase (MPO) in synovia from diseased joints and tendon sheaths in the horse and its relationship to other synovial parameters and clinical signs of orthopedic diseases. Materials and Method: A total of 88 synovia samples were obtained from healthy joints (n=18) and from diseased joints (n=62) and tendon sheaths (n=8) of a total of 74 horses. Clinical diagnosis was achieved through anamnesic data, clinical and roentgenographic examination, and analysis of synovial fluid. An ultrasound examination was performed on the diseased tendon sheaths. Based on this information, samples were classified into 7 diagnostic groups: healthy controls (C) (n=18), chronic arthritis (CA) (n=28), osteoarthritis (OA) (n=12), osteochondrosis dissecans (OCD) (n=15), osteochondrosis dissecans with secondary osteoarthritis (OCD + osteoarthritis) (n=4), tenosynovitis (TS) (n=8) and septic arthritis (SA) (n=3). Synovial fluid was analyzed for pH, total protein concentration, total white blood cell count, viscosity and activity of MPO. The activity of MPO in synovia was compared irrespective of the clinical diagnosis with synovial pH, total protein concentration, total white blood cell count, synovial viscosity, and the degree of lameness. Results: pH mean value in the control group was 7, 377 ± 0, 062 (range: 7, 239 7, 491). The lowest pH mean was detected in the group of SA (7, 274 ± 0, 071; range: 7, 200 7, 342). At least 75% of all samples from the groups of CA, OA, OCD, OCD + osteoarthritis and TS presented pH values within the range observed in the controls. This was also the case for 2 of the 3 samples diagnosed with SA. Synovial mean total protein concentration was 0, 867 ± 0, 491 (range: 0, 1 1, 8 g/dl). At least 75% of the samples from the groups of CA, OA, OCD, OCD + osteoarthritis showed values equal or below 1, 2 g/dl. Mean total protein concentration was higher in the groups of TS (mean: 2, 025 ± 1, 358 g/dl; range: 0, 4 4, 2 g/dl) and SA (mean: 3, 867 ± 1, 629; range: 2, 0 ± 5, 0 g/dl). Total white blood cell count in the control group showed a maximum of 500 cells/µl. At least 75% of all samples from the controls and the groups of CA, OA, OCD, OCD + osteoarthritis showed values equal or below 200 cells/ µl. The group of TS showed a total white blood cell count with a range of 400 3200 cells/µl. The groups of SA showed the highest values of this study, with total white blood cell counts ranging from 13 100 to 29 800 cells/µl. MPO-activity mean value for healthy controls was 0, 150 ± 0, 313 mU/µl (range: 0, 0 - 1, 2 mU/µl). MPO-activity of at least 50% of samples from the groups of CA, OA, OCD + osteoarthritis and 75% of samples diagnosed with OCD fell within the range detected in the controls. All three samples from the groups of SA as well as the great majority of samples from the group of TS were above the range observed in the controls but overlapped with activity detected in a few samples from other groups of diseased joints. Viscosity of synovia was normal in all controls samples and in the majority of samples from the groups of OA, OCD, OCD + osteoarthritis. The majority of samples from the group with CA and TS showed decreased or severely decreased viscosity. All three samples from the group of SA presented severely decreased viscosity. All samples from healthy controls as well as the majority of samples from OCD came from sound limbs. Samples from the group of CA came mostly from limbs showing doubtful or mild degrees of lameness. The majority of samples from the group of OA, OCD + osteoarthritis and TS were taken from limbs presenting mild to moderate degrees of lameness. Severe degree of lameness was only observed in all three samples diagnosed with SA. Samples with the same activity of MPO showed different values of pH. Samples showing the same total protein concentration showed different values of MPO-activity. This was also de case for samples with the same total white blood cell count. Samples with a normal viscosity (n=56) presented a mean MPO-activity of 0, 668 ± 1, 520 mU/µl; range: 0, 0 8, 1 mU/µl). The mean value of MPO-activity was higher in the other 2 groups of samples showing a decreased (n=9) or severely decreased (n=23) viscosity. MPO-activity detected in at least 50% of samples with decreased or severely decreased synovial viscosity overlapped with the range of MPO-activity detected in samples with physiologically normal viscosity. Mean activity of MPO was higher in samples obtained from all 4 groups of lame limbs than in synovia acquired from sound limbs. However, MPO-activity of at least 50% of the observation from the groups of doubtful, mild and moderate lameness overlapped with activity of the enzyme detected in the group of sound limbs. Samples from joints of severely lame limbs (n=3) also overlapped with some values detected in the other groups. Conclusion: In the present study, it was impossible to differentiate at least 50% of samples from joints diagnosed with CA, OA, OCD + osteoarthritis and 75% of samples with OCD from normal controls solely based on the activity of MPO. MPO-activity of all 3 samples from the group SA and in the great majority of samples of the group with TS was higher than in healthy controls but overlapped with activities detected in a few samples of joints affected with non-septic conditions. There seems to be no relationship between MPO-activity in synovia and synovial pH, total protein concentration, total white blood cell count or viscosity in the samples analyzed in the present study. Nor does there seem to be any relationship between MPO-activity in synovia and the degree of lameness.Fragestellung: Das Ziel der vorliegenden Arbeit ist die Untersuchung der Aktivität des Enzyms Myeloperoxidase (MPO) in Synovia von erkrankten Gelenken und Sehnenscheiden beim Pferd und deren Zusammenhang mit anderen synovialen Parametern und klinischen Symptomen von orthopädischen Erkrankungen. Material und Methode: Von insgesamt 74 Pferden wurden 88 Synoviaproben gewonnen. Die Probenentnahme erfolgte aus gesunden (n=18) und erkrankten (n=62) Gelenken sowie aus erkrankten Sehnenscheiden (n=8). Die klinische Diagnose wurde aufgrund der Anamnese, der klinischen Erscheinungen sowie der Röntgen- und Ultraschalluntersuchung und Ermittlung weiterer synovialer Parameter gestellt. Die Synoviaproben wurden in sieben unterschiedliche Gruppen eingeteilt: Kontrolle (C) (n=18), chronische Arthritis (CA) (n=28), Osteoarthritis (OA) (n=12); Osteochondrosis dissecans (OCD) (n=15), Osteochondrosis dissecans + sekundäre Osteoarthritis (OCD + osteoarthritis) (n=4), Tendovaginitis (TS) (n=8) und septische Arthritis (SA) (n=3). Die Synovia wurde nach pH-Wert, Gesamtproteinkonzentration, Gesamtleukozytenzahl, Viskosität und MPO-Aktivität untersucht. Die MPO-Aktivität wurde mit dem pH-Wert, der Gesamtproteinkonzentration, der Gesamtleukozytenzahl, der Viskosität der Synovia und mit dem Lahmheitsgrad verglichen. Ergebnisse: Der Mittelwert für den pH-Wert der Kontrollgruppe lag bei 7, 377 ± 0, 062. Den niedrigsten Mittelwert hatte die Gruppe SA (7, 274 ± 0, 071). Jeweils mindestens 75% der Proben der Gruppen CA, OA, OCD, OCD + osteoarthritis und TS hatten pH-Werte, die sich im Bereich der Kontrollgruppe befanden. Dies war auch der Fall bei zwei von den drei Proben der Gruppe SA. Die Gesamtproteinkonzentration in den Synoviaproben der gesunden Kontrolgruppe lag bei 0,867 ± 0, 491 g/dl. Mindestens 75% der Proben der Gruppen CA, OA, OCD, OCD + osteoarthritis hatten Werte gleich oder unterhalb von 1, 2 g/dl. Eine höhere mittlere Gesamtproteinkonzentration trat in den Gruppen TS (Mittelwert: 2, 025 ± 1, 358 g/dl) und SA auf (Mittelwert: 3, 867 ± 1, 629 g/dl). Die Gesamtleukozytenzahl in der Kontrollgruppe zeigte ein Maximum von 500 Zellen/μl. Jeweils mindestens 75% aller Proben der Kontrollgruppe und der Gruppen CA, OA, OCD, OCD + osteoarthritis lagen unterhalb einer Gesamtleukozytenzahl von 200 Zellen/μl. Die Werte für die Proben der Gruppe TS befanden sich zwischen 400 3200 Zellen/μl. In der Gruppe SA traten die höchsten Werte auf (zwischen 13 100 29 800 Zellen/μl). Die mittlere MPO-Aktivität der Kontrollgruppe war 0, 150 ± 0, 313 mU/μl. Jeweils mindestens 50% der Proben der Gruppen CA, OA, OCD + osteoarthritis und 75% der Proben der Gruppe OCD befanden sich innerhalb der Werte der Kontrollgruppe. Alle drei Proben der Gruppe SA sowie die Mehrheit der Proben der Gruppe TS hatten eine höhere MPO-Aktivität als die der Kontrollgruppe. Die Werte überlappten sich mit Werten einiger Proben der restlichen Gruppen von erkrankten Gelenken. Alle Synoviaproben der gesunden Kontrollgruppe und die Mehrheit der Proben der Gruppe OCD wurden von Gliedmaßen gewonnen, die keine Lahmheit zeigten. Proben der Gruppe CA kamen überwiegen von Gliedmaßen mit undeutlichem oder geringgradigem Lahmheitsgrad. Die Mehrheit der Proben der Gruppen OA, OCD + osteoarthritis und TS stammte von Gliedmaßen mit geringgradigen oder mittelgradigen Lahmheiten. Hochgradige Lahmheiten zeigten nur die drei Pferde mit septischer Arthritis. Die Viskosität der Synovia war in der Kontrollgruppe und bei der Mehrheit der Proben der Gruppen OA, OCD, OCD + osteoarthritis unverändert. Die Mehrheit der Proben der Gruppen CA und TS zeigte eine verminderte oder stark verminderte Viskosität. Bei allen drei Proben der Gruppe SA war die Viskosität stark vermindert. Synoviaproben mit gleicher MPO-Aktivität zeigten unterschiedliche pH-Werte. Unterschiedliche MPO-Aktivitäten wurden in Proben mit der gleichen Gesamtproteinkonzentration nachgewiesen. Dies war auch der Fall für Proben mit der gleichen Gesamtleukozytenzahl. Proben mit einer normalen Viskosität (n=56) zeigten eine mittlere MPO-Aktivität von 0, 668 ± 1, 520 mU/μl. Die mittlere MPO-Aktivität war höher in den anderen zwei Gruppen, die eine verminderte (n=9) oder stark verminderte (n=23) Viskosität zeigten. Jedoch überlappten sich die Werte von mindestens 50% der Proben der Gruppen mit verminderter oder stark verminderter Viskosität mit den Werten der Synoviaproben mit einer normalen Viskosität. Alle vier Gruppen, die auch klinisch eine Lahmheit zeigten, hatten eine höhere mittlere MPO-Aktivität, als die Gruppen, deren Proben von nicht-lahmen Gliedmaßen stammten. Jedoch überlappten sich die Werte von mindestens 50% der Proben, die als undeutlich, gering- oder mittelgradig- lahm eingestuft worden waren, mit den Werten der Synoviaproben von nicht- lahmen Gelenken. Die MPO-Aktivität von Synoviaproben aus Gelenken hochlahmer Gliedmaßen überlappte sich außerdem mit der Aktivität von einigen Proben der anderen Gruppen mit geringerem Lahmheitsgrad. Schlussfolgerungen: Aufgrund der Messung der MPO-Aktivität in der Synovia ist es bei 50% der Proben der Gruppen von CA, OA, OCD + osteoarthritis und bei 75% der Proben von OCD unmöglich diese von den gesunden Kontrollen zu unterscheiden. Nur die MPO-Aktivität aller drei Proben von der Gruppe SA und des größten Teils der Proben der Gruppe TS war höher als die der Kontrollgruppe, aber sie überlappte sich mit der Aktivität einiger Proben aus nicht-septisch erkrankten Gelenken. Es scheint keinen Zusammenhang zwischen der MPO-Aktivität der Synovia und deren pH-Wert, Gesamtproteinkonzentration, Gesamtleukozytenzahl und Viskosität sowie dem Grad der Lahmheit zu geben

Thermal Flow Measurements by a Flexible Sensor, Implemented on the External Surface of the Flow Channel

AbstractA thermal gas flow sensor was developed and evaluated. The presented implementation requires only low-cost manufacturing techniques and readily available components, while maintaining a high level of detection range and sensitivity. Heater and sensing elements were integrated on a flexible substrate and the device was formed by bending the substrate so that the active elements were placed on the external surface of the formed channel, therefore zero flow interference is achieved and a wide variety of fluids can be measured without compromising the sensor integrity. Evaluation was made using air flow rates in the range of 0-65SLPM utilizing electrical measurements and IR imaging techniques simultaneously

StreetScouting dataset: A Street-Level Image dataset for finetuning and applying custom object detectors for urban feature detection

The recent advancements in the field of deep learning have fundamentally altered the manner in which certain challenges and problems are addressed. One area that stands to greatly benefit from such innovations is the realm of urban planning, where the utilization of these tools can facilitate the automatic detection of landscape objects in a given area. However, it must be noted that these data-driven methodologies necessitate significant amounts of training data to attain desired results. This challenge can be mitigated through the application of transfer learning techniques, which reduce the amount of required data and permit the customization of these models through fine-tuning. The present study presents street-level imagery, which can be utilized for fine-tuning and deployment of custom object detectors in urban environments.The dataset comprises 763 images, each accompanied by bounding box annotations for five landscape object classes, including trees, waste bins, recycling bins, shop storefronts, and lighting poles. Furthermore, the dataset includes sequential frame data obtained from a camera mounted on a vehicle, capturing a total of three hours of driving, encompassing various regions within the city center of Thessaloniki

Serum Amyloid A (SAA) Concentration after Vaccination in Horses and Mules

Serum amyloid A (SAA) is a sensitive acute-phase response (APR) marker in equids. Prominent APRs with elevations of SAA concentrations ([SAA]) have been reported after vaccination. The authors hypothesized that vaccination with an inactivated EHV-1/-4 vaccine would cause increase in [SAA] and antibody responses and that higher [SAA] would be positively correlated with the antibody titer in both equids. Twelve Haflinger horses and 12 mules were included in this longitudinal prospective study. All horses and mules were vaccinated with a commercially available EHV-1/-4 vaccine. Blood was sampled before and after vaccination to measure [SAA] and virus-neutralizing response (VN-T). In horses and mules, significantly higher [SAA] were measured on days 1, 3, and 5 after EHV-1/-4 vaccination; [SAA] on day 1 after vaccination were only measured in animals that developed fever, where mean [SAA] were significantly higher in horses than in mules (horses: 1,365.75 ± 87.64 mg/L, mules: 615.5 ± 153.444 mg/L) (P >.05). Four horses and 2 mules developed fever after vaccination, lasting for ≤24 hours. Increased antibody responses (VN-T) on days 7 and 14 after vaccination were observed in all animals, whereas mules showed higher overall antibody responses. Nevertheless, [SAA] did not correlate with the intensity of the antibody responses (VN-T) stimulated by the vaccine (

Osteopontin drives KRAS-mutant lung adenocarcinoma

Increased expression of osteopontin (SPP1) is associated with aggressive human lung adenocarcinoma, but its function remains unknown. Our aim was to determine the role of SPP1 in smoking-induced lung adenocarcinoma. We combined mouse models of tobacco carcinogen-induced lung adenocarcinoma, of deficiency of endogenous Spp1 alleles, and of adoptive pulmonary macrophage reconstitution to map the expression of SPP1 and its receptors and determine its impact during carcinogenesis. Co-expression of Spp1 and mutant KrasG12C in benign cells was employed to investigate SPP1/KRAS interactions in oncogenesis. Finally, intratracheal adenovirus encoding Cre recombinase was delivered to LSL.KRASG12D mice lacking endogenous or overexpressing transgenic Spp1 alleles. SPP1 was overexpressed in experimental and human lung adenocarcinoma and portended poor survival. In response to two different smoke carcinogens, Spp1-deficient mice developed fewer and smaller lung adenocarcinoma with decreased cellular survival and angiogenesis. Both lung epithelial- and macrophage-secreted SPP1 drove tumor-associated inflammation, while epithelial SPP1 promoted early tumorigenesis by fostering the survival of KRAS-mutated cells. Finally, loss and overexpression of Spp1 was, respectively, protective and deleterious for mice harboring KRASG12D-driven LADC. Our data support that SPP1 is functionally involved in early stages of airway epithelial carcinogenesis driven by smoking and mutant KRAS and may present an important therapeutic target